Shree Hari Chemicals board re-appoints CMD and adds independent director

scanx
Reviewed by
Riya DScanX News Team
Key Highlights
  • Board re-appointed CMD Bankesh Chandra Agrawal and WTDs Sarthak and Nihit Agarwal for three-year terms
  • Independent Director Shri Ram Gupta re-appointed for a second five-year term starting September 29, 2026
  • Amrut Urkude appointed as additional independent director effective August 25, 2026
  • All appointments require shareholder approval under SEBI LODR Regulations
powered bylight_fuzz_icon
49218587

*this image is generated using AI for illustrative purposes only.

Shree Hari Chemicals Export Limited’s Board of Directors held a meeting on August 25, 2026, to approve the re-appointment of its Chairman & Managing Director and two Whole Time Directors for three-year terms. The board also appointed an additional independent director.

The approvals are subject to shareholder consent. All appointments align with SEBI Listing Obligations and Disclosure Requirements Regulations, 2015.

Key Appointments

The board considered and approved the following changes to its composition:

Director Role Term Start Duration
Bankesh Chandra Agrawal Chairman & Managing Director November 11, 2026 Three years
Sarthak Agarwal Whole Time Director November 11, 2026 Three years
Nihit Agrawal Whole Time Director November 11, 2026 Three years
Shri Ram Gupta Independent Director September 29, 2026 Five years (second term)
Amrut Urkude Additional Independent Director August 25, 2026 Five years

Bankesh Chandra Agrawal, 74, brings over 49 years of experience in the yarn and chemical industries. Sarthak Agarwal, 34, has more than 13 years of experience in textile and chemical business. Nihit Agarwal, 32, holds a B.Tech degree and has over 10 years of industry experience.

Shri Ram Gupta, 70, is a Chartered Accountant with 44 years of experience in finance, banking, and taxation. Amrut Urkude, 54, holds a Doctorate in Management Studies and has over 30 years of experience in corporate governance and organizational leadership.

Governance Disclosures

The filing confirms that none of the directors have been debarred from holding office by SEBI or any other authority. Relationships between directors were disclosed as follows:

  • Bankesh Chandra Agrawal, Sarthak Agarwal, Nihit Agarwal, and Non-executive Director Vikas Agarwal are related.
  • Shri Ram Gupta and Amrut Urkude are not related to promoters or other directors.

The board meeting commenced at 12:15 pm and concluded at 6:00 pm.

Historical Stock Returns for Shree Hari Chemicals Export

1 Day5 Days1 Month6 Months1 Year5 Years
+4.97%-2.92%+24.34%+54.23%+59.73%+191.32%

How might the re-appointment of the Agarwal family members influence Shree Hari Chemicals' strategic direction and succession planning over the next three years?

What specific expertise does the newly appointed independent director, Amrut Urkude, bring that could enhance the company's corporate governance or risk management frameworks?

Will the upcoming shareholder vote on these appointments signal any potential dissent regarding the current board composition or management structure?

Shree Hari Chemicals Export
View Company Insights
View All News
like20
dislike

Shree Hari Chemicals approves ₹40.24 Cr preferential warrant issue

scanx
Reviewed by
Ashish TScanX News Team
Key Highlights
  • Preferential issue of 22,85,000 convertible warrants approved
  • Aggregate value of ₹40.24 crore at ₹176.10 per warrant
  • Allotted to four promoter entities including Nihit Agarwal
  • Conversion into equity shares required within 18 months
  • Post-conversion promoter holding ranges from 5.36% to 8.13%
powered bylight_fuzz_icon
49218580

*this image is generated using AI for illustrative purposes only.

Shree Hari Chemicals Export approved a preferential issue of 22,85,000 convertible warrants aggregating to ₹40.24 crore on August 25, 2026. The board meeting authorized the issuance at a price of ₹176.10 per warrant, subject to shareholder approval.

The warrants are allotted to four promoter entities: Shri Nihit Agarwal, Smt Priyamvada Agarwal, Smt Avanticka Agarwal, and Smt Smradhi Agarwal. Each warrant is convertible into one equity share of face value ₹10 at a premium of ₹166.10 per share.

Issue Structure

The company outlined the payment terms and conversion timeline for the instruments. Investors must pay 25% of the issue price at the time of subscription and allotment. The remaining 75% is due on or before the exercise of the conversion right.

Conversion must occur in one or more tranches within 18 months from the date of allotment. The company will intimate the stock exchange upon conversion or lapse of the instrument tenure.

Promoter Shareholding Impact

The table below details the proposed allotment and the resulting post-conversion shareholding pattern for the promoters.

Allottee Warrants Issued Pre-Issue Shares Post-Conversion Shares Post-Conversion %
Shri Nihit Agarwal 6,85,500 3,000 6,88,500 8.01%
Smt Priyamvada Agarwal 6,85,500 13,784 6,99,284 8.13%
Smt Avanticka Agarwal 4,57,000 4,107 4,61,107 5.36%
Smt Smradhi Agarwal 4,57,000 37,000 4,94,000 5.75%

The post-conversion percentages reflect the expected ownership assuming full conversion of all issued warrants within the stipulated period.

Historical Stock Returns for Shree Hari Chemicals Export

1 Day5 Days1 Month6 Months1 Year5 Years
+4.97%-2.92%+24.34%+54.23%+59.73%+191.32%

How will the ₹40.24 crore capital infusion impact Shree Hari Chemicals' liquidity position and its ability to fund upcoming expansion projects?

What is the strategic rationale behind issuing convertible warrants to promoters at a premium of ₹166.10 per share rather than raising funds from external institutional investors?

Will the post-conversion increase in promoter holding to approximately 27.25% enhance market confidence in management's long-term commitment to the company?

Shree Hari Chemicals Export
View Company Insights
View All News
like18
dislike

More News on Shree Hari Chemicals Export

1 Year Returns:+59.73%